Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43

Amyloid

Volumn 5, Issue 1, 1998, Pages 10-15

  Muller W E ^a,b   Eckert, G P ^a,b   Scheuer, K ^a   Cairns, N J ^c   Maras, A ^a   Gattaz, W F ^a,d  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Apolipoprotein E; Beta amyloid; Membrane fluidity; Neurotoxicity

Indexed keywords

1 (4 (TRIMETHYLAMINO)PHENYL) 6 PHENYLHEXA 1,3,5 TRIENE; 1,6 DIPHENYL 1,3,5 HEXATRIENE; 1-(4-(TRIMETHYLAMINO)PHENYL)-6-PHENYLHEXA-1,3,5-TRIENE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 43); AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (1-43); AMYLOID BETA-PROTEIN (25-35); APOLIPOPROTEIN E; DRUG DERIVATIVE; FLUORESCENT DYE; PEPTIDE FRAGMENT; PHOSPHOLIPID;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL MEMBRANE; DRUG EFFECT; FEMALE; FLUORESCENCE POLARIZATION; HUMAN; LIPID BILAYER; MALE; MEMBRANE FLUIDITY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BRAIN; CELL MEMBRANE; DIPHENYLHEXATRIENE; FEMALE; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; HUMANS; LIPID BILAYERS; MALE; MEMBRANE FLUIDITY; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS;

EID: 0032014429     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809007284     Document Type: Article

References (34)

1. Hyman BT, Marzloff K and Arriagada PV (1993). The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 52, 594-600
2. McGeer PL, Klegeris A, Walker DG, Yasuhara O and McGeer EG (1994). Pathological proteins in senile plaques. Tohoku J Exp Med 174, 269-77
3. Pike CJ, Walencewicz AJ, Glabe CG and Cotman CW (1991). In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563, 311-4
4. Yankner BA, Duffy L and Kirschner DA (1990). Neurotrophic and neurotoxic effects of beta-amyloid protein: reversal by tychykinin neuropeptides. Science 250, 279-82
5. Aksenov MY, Aksenova MV, Harris ME, Hensley K, Butterfield DA and Carney JM (1995). Enhancement of beta-amyloid peptide (1-40)-mediated neurotoxicity by glutamine synthetase. J Neurochem 65, 1899-902
6. Kelly JF, Furukawa K, Barger SW, Rengen MR, Mark RJ, Blanc EM, Roth GS and Mattson MP (1996). Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc Natl Acad Sci USA 93, 6753-8
7. Müller WE, Koch S, Eckert A, Hartmann H and Scheuer K (1995). Beta-amyloid peptide decreases membrane fluidity. Brain Res 674, 133-6
8. Terzi E, Holzemann G and Seelig J (1995). Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J Mol Biol 252, 633-42
9. Mattson MP, Rydel RE, Lieberburg I and Smith Swintosky VL (1993). Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples. Ann N Y Acad Sci 679, 1-21
10. Hartmann H, Eckert A and Muller WE (1994). Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem Biophys Res Commun 200, 1185-92
11. Hartmann H, Eckert A, Crews FT and Müller WE (1996). Beta-amyloid peptide amplifies PLC activity and Ca2+ signalling in fully differentiated brain cells of adult mice. Amyloid Int J Exp Clin Invest 3, 234-41
12. Carette B, Poulain P and Delacourte A (1993). Electrophysiological effects of (25-35) amyloid-beta-protein on guinea-pig lateral septal neurons. Neurosci Lett 151, 111-4
13. Iversen LL, Mortishire Smith RJ, Pollack SJ and Shearman MS (1995). The toxicity in vitro of beta-amyloid protein. Biochem J 311, 1-16
14. Mason RP, Estermyer JD, Kelly JF and Mason PE (1996). Alzheimer's disease amyloid beta-peptide (25-35) is localized in the membrane hydrocarbon core: x-ray diffraction analysis. Biochem Biophys Res Commun 222, 78-82
15. Pollard HB, Rojas E and Arispe N (1993). A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein in phospholipid bilayer membranes. Ann N Y Acad Sci 695, 165-8
16. Davenport L, Dale RE, Bisby RH and Cundall RB (1985). Transverse location of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene in model lipid bilayer membrane systems by resonance excitation energy transfer. Biochemistry 24, 097-108
17. Prendergast FG, Haugland RP and Callahan PJ (1981). 1-[4-(trimethyl-amino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20, 7333-8
18. Shinitzky M (1984). Membrane Fluidity and Cellular Functions, pp. 1-51. (Boca Raton, Florida: CRC Press)
19. Lowry O, Rosenbroughm NI, Farr AL and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-75
20. Lentz BR (1988). Membrane fluidity from anisotropy measurements. In Loew LM (ed.) Spectroscopic Membrane Probes, pp. 13-42. (Boca Raton, Florida: CRC Press)
21. Mulders F, van Langen H, Van Ginkel G, and Levine YK. The static and dynamic behaviour of fluourescent probe molecules in lipid bilayers. Biochim Biophys Acta 1986;859209-18
22. Pirttilä T, Soininen H, Mehta PD, Heinonen O, Lehtimaeki T, Bogdanovic N, Paljaervi L, Kim KS, Kosunen O, Winblad B (1996). Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging 18, 121-7
23. Chauhan A, Chauhan VPS, Brockerhof fH and Wisniewski HM (1993). Effect of amyloid beta-protein on membrane properties. In Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H and Zatta P (ed.) Alzheimer's Disease: Advances in Clinical and Basic Research, pp. 431-9. (New York: John Wiley & Sons Ltd)
24. Pike CJ, Walencewicz Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG and Cotman CW (1995). Structure-activity analyses of beta-amyloid peptides: contributions of the beta (25-35) region to aggregation and neurotoxicity. J Neurochem 64, 253-65
25. Wood SJ, Maleeff B, Hart T and Wetzel R (1996). Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol 256, 870-7
26. Terzi E, Holzemann G and Seelig J (1994). Alzheimer's beta-amyloid peptide (25-35): electrostatic interactions with phospholipid membranes. Biochemistry 33, 7434-41
27. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN (1994). Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45, 373-9
28. Barrow CJ, Yasuda A, Kenny PT and Zagorski MG (1992). Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol 225, 1075-93
29. Ghiso J, Rostagno JE, Liem L, Gorevic PD, and Frangione B (1992). A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J 288, 1053-9
30. Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT and Mirra SS (1995). Regional variation in the distribution of apolipoprotein E and amyloid beta-peptide in Alzheimer's disease. J Neuropathol Exp Neurol 54, 833-41
31. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EHX, Saunders AM and Schmechel DE (1994). Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 343, 1564-5
32. Golabek AA, Soto C, Vogel T and Wisniewski T (1996). The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J Biol Chem 271, 10602-6
33. Wood SJ, MacKenzie L, Maleeff B, Hurle MR and Wetzel R (1996). Selective inhibition of amyloid beta-peptide fibril formation. J Biol Chem 271, 4086-92
34. Whitson JS, Minis MP, Strittmatter WJ, Yamaki T, Morisett JD and Appel SH (1996). Attenuation of the neurotoxic effect of beta-amyloid peptide by apolipoprotein E. Biochem Biophys Res Commun 199, 163-70